scispace - formally typeset
Open AccessJournal ArticleDOI

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.

Reads0
Chats0
TLDR
In this article, the authors describe the long-term health consequences of patients with COVID-19 who have been discharged from hospital and investigate the associated risk factors, in particular disease severity.
About
This article is published in The Lancet.The article was published on 2021-01-16 and is currently open access. It has received 2933 citations till now. The article focuses on the topics: Pulmonary diffusion & Severity of illness.

read more

Citations
More filters
Journal ArticleDOI

Long-term gastrointestinal outcomes of COVID-19

TL;DR: In this article , the authors used the US Department of Veterans Affairs national health care databases to build a cohort of 154,068 people with COVID-19, 5,638,795 contemporary controls, and 5,859,621 historical controls to estimate the risks and 1-year burdens of a set of pre-specified incident gastrointestinal outcomes.
Journal ArticleDOI

Seroprevalence of SARS-CoV-2 antibodies among hospital staff in rural Central Fukushima, Japan: A historical cohort study.

TL;DR: In this paper, a two-time survey was performed in May and October 2020 for 545 hospital staff to investigate the changes in the results of the rapid kit test and chemiluminescence immunoassay (CLIA).
Journal ArticleDOI

Post-COVID Syndrome.

TL;DR: In this paper , the authors defined post-COVID syndrome (PCS) as a group of symptoms that can occur following the acute phase of a SARS-CoV-2 infection and as a consequence thereof.
References
More filters
Journal ArticleDOI

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)

TL;DR: A 5-level version of the EQ-5D has been developed by the EuroQol Group and further testing is required to determine whether the new version improves sensitivity and reduces ceiling effects.
Journal ArticleDOI

Dexamethasone in Hospitalized Patients with Covid-19

TL;DR: In patients hospitalized with Covid-19, the use of dexamethasone resulted in lower 28-day mortality among those who were receiving either invasive mechanical ventilation or oxygen alone at randomization but not among those receiving no respiratory support.
Related Papers (5)
Trending Questions (1)
What is the implications of reshoring after covid?

The given text does not provide any information about the implications of reshoring after COVID-19.